Alerte De Sécurité sur Chemistry Calibrator, 12 vials X 3 mL, Registration No. 10345160486, lot: 090445B, 090445C

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par Siemens Healthcare Diagnósticos Ltda..

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    1310
  • Date
    2013-09-24
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    According to the company's manifestation, the slight positive change in direct bilirubin is observed in values ​​approximately ten times greater than the reference limit. In cases of hyperbilirubinemia due to hepatic obstruction, the change will have no impact on the use of the assay for diagnostic support. For instances of hyperbilirubinemia, which test is used to estimate indirect bilirubin in conjunction with total bilirubin, total bilirubin will be slightly underestimated. However, the clinical interpretation of the results will not be affected. For patients with elevated bilirubin overestimation will not impact treatment, since the values ​​will still support both diagnosis and prognosis. For determination of total bilirubin, a proportional decrease in indirect bilirubin will have no impact on the most vulnerable population - newborns due to immaturation of the glucuronidation pathway, so most circulating bilirubin will still be the indirect one.
  • Cause
    Siemens healthcare diagnostics has identified that the system specific values ​​for the direct calibrator (dbil_2) of the chemistry calibrator, batches 090445b and 090445c belonging to the advia® chemistry 1200, 1650, 1800 and 2400 systems, may cause a + 7-9% in quality control and sample recovery at 3 mg / dl.
  • Action
    The registrant in Brazil reported that customers were instructed to use the new System Specific Values ​​reassigned for the Direct Bilirubin Assay (DBIL_2) of the Chemistry Calibrators, batches 090445B and 090445C, provided in Table 2 of the notification is attached to this alert) and to keep the letter with the records of the Laboratory.

Manufacturer

  • Société-mère du fabricant (2017)
  • Source
    ANVSANVISA